Lauren Mastrocola's most recent trade in Praxis Precision Medicines Inc was a trade of 40 Common Stock done at an average price of $85.4 . Disclosure was reported to the exchange on Feb. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.40 per share. | 12 Feb 2025 | 40 | 10,441 | - | 85.4 | 3,416 | Common Stock |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 5,000 | 10,871 | - | 0 | Common Stock | |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.15 per share. | 10 Jan 2025 | 390 | 10,481 | - | 63.2 | 24,629 | Common Stock |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.51 per share. | 07 Jan 2025 | 35 | 5,871 | - | 77.5 | 2,713 | Common Stock |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 81.79 per share. | 14 Nov 2024 | 5,188 | 5,612 | - | 81.8 | 424,318 | Common Stock |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.94 per share. | 14 Nov 2024 | 4,374 | 10,801 | - | 56.9 | 249,056 | Common Stock |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 4,374 | 16,626 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 37.40 per share. | 14 Nov 2024 | 294 | 5,906 | - | 37.4 | 10,996 | Common Stock |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 4,500 | 6,427 | - | 0 | Common Stock | |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.65 per share. | 12 Feb 2024 | 48 | 1,927 | - | 44.6 | 2,143 | Common Stock |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.20 per share. | 07 Jan 2024 | 35 | 1,975 | - | 25.2 | 882 | Common Stock |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.94 per share. | 12 Feb 2023 | 711 | 30,160 | - | 3.9 | 2,801 | Common Stock |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 3,110 | 3,110 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.52 per share. | 07 Jan 2023 | 520 | 30,871 | - | 2.5 | 1,310 | Common Stock |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Purchase of securities on an exchange or from another person at price $ 1.92 per share. | 16 Jun 2022 | 3,000 | 31,391 | - | 1.9 | 5,775 | Common Stock |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 8.80 per share. | 13 May 2022 | 2,557 | 28,391 | - | 8.8 | 22,496 | Common Stock |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.85 per share. | 12 Feb 2022 | 584 | 25,834 | - | 12.8 | 7,504 | Common Stock |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 21,000 | 21,000 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 6,000 | 26,418 | - | 0 | Common Stock | |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 48,700 | 48,700 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 8,200 | 20,418 | - | 0 | Common Stock | |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 12,218 | 15,710 | - | - | Stock Option (Right to Buy) | |
| Praxis Precision Medicines... | Lauren Mastrocola | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.30 per share. | 02 Nov 2020 | 12,218 | 12,218 | - | 3.3 | 40,319 | Common Stock |